Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TGIF2-C20orf24 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM70 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
LY6E - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
ALDH1A3 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
RHOF - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
EXOSC4 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
YWHAB - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
MIR4683 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
PI3 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
LGALS1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
TM7SF3 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
NPAS2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
KLHL5 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
EPS8L2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
KRT81 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
UBASH3B - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
LGALS3 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on